On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced^[1] that it updated its Code on Interactions with Health Care Professionals^[2] (“PhRMA Code”). The PhRMA Code was previously updated in 2019 and is a voluntary code of ethics applicable to pharmaceutical company interactions with US health care professionals (HCPs). The PhRMA code will take effect on January 1, 2022. The most significant PhRMA updates relate to speaker programs and speaker training meetings.

Read our alert for a summary of the new insertions into the PhRMA code and other critical changes and to explore Deloitte’s insights on what it means for life sciences organizations.

¹ PhRMA, “Statement on Revisions to the PhRMA Code on Interactions with Health Care Professionals,” Speeches & Communication, August 6, 2021.
² PhRMA, “Code on Interactions with Health Care Professionals,” effective January 1, 2022.

More life sciences trends and insights

• Read Deloitte's 2021 global life sciences outlook for insights on how life sciences companies continue to respond to the impacts of the pandemic and in what areas they can build resilience going forward

• Learn why, in the future of health, engaging with regulators and staying abreast of legislative and regulatory activity will be more important than ever for life sciences organizations

• Understand how pharma and medtech can shift from doing digital to being digital

• Gain insights into how AI is already helping to improve process efficiency in the life sciences industry